- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Baltimore to Head Caltech
13 May 1997 (All day)
In a surprising move, the California Institute of Technology announced today that it has named Nobel Prize-winning virologist David Baltimore as its new president. "It's a great appointment for Caltech and a wonderful opportunity for David Baltimore," says Stanford's Paul Berg, also a Nobel laureate.
Science historian Daniel Kevles, chair of Caltech's faculty, says, "I think everybody wins." Last year, Kevles wrote a New Yorker magazine article about the "resurrection" of Baltimore, who returned to the Massachusetts Institute of Technology in 1994 after resigning as president of Rockefeller University in New York City. Baltimore stepped down from the Rockefeller post in the midst of a bruising public battle with Representative John Dingell (D-MI) over charges that a former colleague, whom Baltimore defended, had committed scientific misconduct. He was vindicated when the charges were finally dismissed last year.
Baltimore plans to continue as chair of an AIDS vaccine advisory committee at the National Institutes of Health, a post he took last January. "That was a long-term commitment, and the committee has only just started to reshape the vaccine research program," he said in a statement. Baltimore will replace Thomas Everhart, Caltech's president for 10 years, this fall.